COVID-19 in India: Are Biological and Environmental Factors Helping to Stem the Incidence and Severity?
ACE2
COVID-19
India
cross-immunity
mortality
transmission
Journal
Aging and disease
ISSN: 2152-5250
Titre abrégé: Aging Dis
Pays: United States
ID NLM: 101540533
Informations de publication
Date de publication:
May 2020
May 2020
Historique:
received:
26
03
2020
accepted:
02
04
2020
entrez:
4
6
2020
pubmed:
4
6
2020
medline:
4
6
2020
Statut:
epublish
Résumé
The ongoing Corona virus (COVID-19) pandemic has witnessed global political responses of unimaginable proportions. Many nations have implemented lockdowns that involve mandating citizens not to leave their residences for non-essential work. The Indian government has taken appropriate and commendable steps to curtail the community spread of COVID-19. While this may be extremely beneficial, this perspective discusses the other reasons why COVID-19 may have a lesser impact on India. We analyze the current pattern of SARS-CoV-2 transmission, testing, and mortality in India with an emphasis on the importance of mortality as a marker of the clinical relevance of COVID-19 disease. We also analyze the environmental and biological factors which may lessen the impact of COVID-19 in India. The importance of cross-immunity, innate immune responses, ACE polymorphism, and viral genetic mutations are discussed.
Identifiants
pubmed: 32489695
doi: 10.14336/AD.2020.0402
pii: ad-11-3-480
pmc: PMC7220291
doi:
Types de publication
Journal Article
Langues
eng
Pagination
480-488Informations de copyright
Copyright: © 2020 Chakrabarti et al.
Références
Indian J Med Res. 2019 Apr;149(4):447-467
pubmed: 31411169
Cell Discov. 2020 Feb 24;6:11
pubmed: 32133153
Front Immunol. 2020 Feb 26;11:334
pubmed: 32174923
Lancet Infect Dis. 2015 May;15(5):559-64
pubmed: 25863564
J Infect. 2013 Aug;67(2):130-40
pubmed: 23583636
Aging Dis. 2020 Mar 9;11(2):216-228
pubmed: 32257537
J Autoimmun. 2020 May;109:102433
pubmed: 32113704
J Med Virol. 2020 May;92(5):518-521
pubmed: 32022275
J Infect Dis. 2005 Jun 15;191(12):2033-7
pubmed: 15897988
Sci Data. 2018 Oct 30;5:180214
pubmed: 30375988
Antivir Ther. 2007;12(4 Pt B):651-8
pubmed: 17944272
Neurol Sci. 2018 Nov;39(11):1965-1969
pubmed: 30090985
Travel Med Infect Dis. 2008 Jan-Mar;6(1-2):67-81
pubmed: 18342278
Immunol Res. 2012 Sep;53(1-3):148-61
pubmed: 22434513
Nat Rev Gastroenterol Hepatol. 2020 May;17(5):259
pubmed: 32214231
J Immunol Res. 2019 Sep 2;2019:7239347
pubmed: 31565661
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
Methods Mol Biol. 2015;1282:1-23
pubmed: 25720466
JAMA. 2020 Mar 11;:
pubmed: 32159775
J Med Virol. 2020 Apr;92(4):424-432
pubmed: 31981224
Aging Dis. 2020 Mar 9;11(2):462-464
pubmed: 32257554